Merck & Co (NYSE: $MRK) is a multinational pharmaceutical company that offers innovative health solutions to millions of patients via prescriptions, therapies, vaccines, and animal […]
Tag: Merck
Merck’s (NASDAQ: $MRK) $680M Harpoon Therapeutics Acquisition Further Diversifies Oncology Pipeline
Merck & Co. (NASDAQ: $MRK) will acquire Harpoon Therapeutics for $680 million in a push to consolidate its leadership position in the oncology space. According […]
Moderna, Inc. (NASDAQ: $MRNA) Soars on Cancer Vaccine Data
Moderna (NASDAQ: $MRNA) stock experienced a surge of approximately 14% on Thursday following news that its personalized cancer vaccine, developed in collaboration with Merck (MRK), […]